HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $7 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen reiterates a Buy rating on Anixa Biosciences (NASDAQ:ANIX) and maintains a $7 price target.
July 24, 2024 | 10:20 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen reiterates a Buy rating on Anixa Biosciences and maintains a $7 price target.
The reiteration of a Buy rating and the maintenance of a $7 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100